Project Grant D43TW013008
- This Project Grant award from the Fogarty International Center (CFDA 93.989 - International Research and Research Training) will support the University of Global Health Equity (UGHE) in Rwanda to decentralize breast biopsy procedures to enable earlier cancer diagnosis and treatment. The $131,278 award, effective September 16, 2025 through August 31, 2030, will fund research to assess the feasibility of implementing decentralized breast biopsy services at district hospitals in Rwanda. This aims...
- This federal Project Grant award for $691,176 from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) supports a study to implement strategies for decentralizing breast ultrasound services and facilitating timely breast cancer diagnoses in Rwanda. The primary objectives are to compare the impact of real-time teleultrasound versus asynchronous virtual supervision on the integration of diagnostic breast ultrasound into district hospitals, as well as the...
- This Project Grant award for $241,888.00, funded by the National Institutes of Health's Fogarty International Center (CFDA 93.989 - International Research and Research Training), supports a comprehensive training program to build scientific leadership and expertise for independent urban malaria epidemiology research in Africa. The key products and services to be delivered include: Providing post-doctoral mentored research training and strengthening the capabilities of 10 post-doctoral...
- This Project Grant award of $442,750 was provided by the National Cancer Institute (NCI) under the federal Cancer Cause and Prevention Research program (CFDA 93.393). The award supports a study led by researchers at New York University (NYU) to identify determinants of successful policy implementation for cervical cancer control in low- and middle-income countries in Africa, as well as potential strategies to strengthen such policy implementation. The research will involve a Delphi process to...
- The University of Maryland, Baltimore received a $248,306 Project Grant award from the Fogarty International Center's International Research and Research Training program (CFDA 93.989) to implement the "Strengthening Surgical Scientists Capacity for NCD-Lifespan Research (SSSCAR) Program". The goal of this 5-year project, starting August 1, 2025, is to build the capacity of the West African College of Surgeons trainees to address surgically amenable non-communicable diseases (NCDs)...
- This Project Grant award from the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) provides $1,231,538.00 to the Dana-Farber Cancer Institute, Inc. (DFCI) to conduct research on genetic testing, counseling, and management of cancer in Africa. The award period runs from July 1, 2024 to June 30, 2027. The project involves conducting cancer genetic testing and counseling initiatives in Rwanda, with a focus on building local capacity and integrating...
- This Project Grant award from the Fogarty International Center (CFDA 93.989 - International Research and Research Training) of $899,426 supports research to establish a national liver cancer treatment outcomes registry and evaluate multidisciplinary tumor board impacts on care delivery and outcomes in Tanzania. The goal is to identify strategies to expand curative treatment for hepatocellular carcinoma (liver cancer) in sub-Saharan Africa, where less than 5% of patients receive curative...
- This federal Project Grant award, provided by the National Cancer Institute (NCI) under the Cancer Research Manpower program (CFDA 93.398), is supporting the development of an automated, multimodal, and multiscale algorithm for cervical cancer screening in low- and middle-income countries (LMICs). The $104,278 award, spanning from Jan 11, 2026 to Jun 30, 2026, is being provided to William Marsh Rice University to pursue three key objectives: 1) designing a multimodal image registration algorithm...
- This $103,950 Project Grant award from the Fogarty International Center (CFDA 93.989 - International Research and Research Training) supports research to develop and validate prostate cancer risk calculators tailored for the Nigerian population. The key objectives are to: (1) Compare the accuracy of existing risk calculators for predicting clinically significant prostate cancer in a Nigerian cohort; (2) Develop new multinomial regression models to predict clinically significant prostate cancer...
- This Project Grant award from the National Cancer Institute (NCI), under the federal Cancer Biology Research program (CFDA 93.396), provides $442,236 to the University of Alabama at Birmingham (UAB) from January 1, 2025 through December 31, 2029. The funding supports research to uncover a novel melanoma metastasis pathway driven by the YTHDF1 RNA-binding protein, and to evaluate therapeutic targeting of the IMPDH1 and TRKB/BDNF pathways that mediate this process. The research utilizes...
This Project Grant award from the Fogarty International Center (CFDA 93.989 - International Research and Research Training) to the Universite des Sciences, des Techniques et des Technologies de Bamako (USTTB) in Mali provides $251,388 in funding to address the increasing burden of breast cancer in Mali and other low- and middle-income countries in Africa. The key objectives of the "Mali-Northwestern University Breast Cancer Prevention (MN-BCP) Research Training Program" are to: 1) Train two PhD-level cancer epidemiologists, one master's-level molecular pathologist, and one biostatistician focused on breast cancer prevention; 2) Create a hybrid Master of Science in Applied Design and Implementation Science in Healthcare at USTTB; and 3) Enhance knowledge, skills, and expertise in breast cancer screening, prevention, and outcomes research among existing public health scientists, clinicians, and stakeholders in Mali. This innovative training program aims to build local research capacity and address the high breast cancer mortality rates in Mali, where the disease affects women at a younger age and is often diagnosed at late stages. The award period runs from August 25, 2025 to May 31, 2030.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 9/23/25 | ||
| Not listed | $251.4k | 8/24/25 |